Odysight.ai Inc., a leader in AI-powered visual sensing and predictive maintenance for defense and industrial sectors, announced that CEO Yehu Ofer will present at the LD Micro 20th Annual Main Event Conference in Los Angeles on October 20, 2026. The presentation will be webcast live, highlighting the company's advanced AI platform that improves safety and efficiency in mission-critical systems. This event offers investors a chance to learn about Odysight.ai's technology, which is used by NASA and defense agencies, and to arrange one-on-one meetings with the CEO. The conference runs from October 19-21, featuring over 100 public companies.
Odysight.ai's upcoming presentation at the LD Micro conference provides context for technology sector performance. For readers following technology stocks, here is Pluang's market snapshot as of Oct 06, 2026 19:01 WIB: Out of 150 priced US technology stocks, 132 rose and 13 fell. Notable movers include Shopify Inc. at USD 165.00 with a 3.05% gain and a typical hold time of 77 days, Applied Digital Corporation at USD 25.39 with a 2.79% gain and 97% buy order activity, and Western Digital Corp at USD 429.45 with a 2.76% loss and 64% sell order activity.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
